¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸ : 2019-09-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸ : 2019-09-27
±³À°ÀÏÀÚ : 2019-09-27
±³À°Àå¼Ò : ºÎ»ê º¤½ºÄÚ 205È£ ¿Ü  
±³À°ÁÖÁ¦ : LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914  
À̸ÞÀÏ : kscp3@kams.or.kr      
±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 18 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í Á¤È¸¿ø 10¸¸¿ø ÁØȸ¿ø 8¸¸¿ø ºñȸ¿ø 25¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-27 205 (2F) 08:00~08:40 KS01: Next generation diagnostic probes for laboratory medicine  Tahir Pillay(University of Pretoria South Africa) 
±³À°½Ã°£ 09-27 205 (2F) 09:00~09:30 SY05: Standardization of lipoprotein testing  Vincent Delatour(Laboratoire National de Métrologie et d) 
±³À°½Ã°£ 09-27 205 (2F) 09:30~10:00 SY05: Nonfasting lipid profiles- are we there yet?  Khushbu Patel(UT Southwestern Medical Center USA) 
±³À°½Ã°£ 09-27 205 (2F) 10:00~10:30 SY05: Triglyceride test with or without free glycerol blanking  Jinsook Lim(Chungnam National University Hospital Korea) 
±³À°½Ã°£ 09-27 201-202 (2F) 08:30~08:45 SY06: POCT in India: Current Scenario and the road ahead  Prasenjit Mitra(All India Institute of Medical Sciences India) 
±³À°½Ã°£ 09-27 201-202 (2F) 08:45~09:00 SY06: Past, Present and Future of Point of Care Testing in Thailand  Nisarat Opartkiattikul(Thai Society of Clinical Pathology Thailand) 
±³À°½Ã°£ 09-27 201-202 (2F) 09:00~09:15 SY06: POCT : current status and future in Mongolia  M. Oyundelger(Mongolian Association of the Laboratory Medicine Mongolia) 
±³À°½Ã°£ 09-27 201-202 (2F) 09:15~09:30 SY06: Practical challenges related to Point-of-care testing  Nguyen Minh Ha(Nguyen Tri Phuong Hospital Vietnam) 
±³À°½Ã°£ 09-27 201-202 (2F) 09:30~09:45 SY06: POCT in Myanmar : Present and Future Prospects  Wah Wah Aung(Ministry of Health and Sports Myanmar) 
±³À°½Ã°£ 09-27 201-202 (2F) 09:45~10:00 SY06: POCT in Taiwan : current and the future  Po-Ren Hsueh(National Taiwan University College of Medicine Taiwan) 
±³À°½Ã°£ 09-27 201-202 (2F) 10:00~10:15 SY06: Present and Future of POCT in Korea  Hyung-Doo Park(Sungkyunkwan University School of Medicine Korea) 
±³À°½Ã°£ 09-27 201-202 (2F) 10:15~10:30 SY06: Implementation POCT in Indonesia  Luci Liana(Fatmawati Hospital Indonesia) 
±³À°½Ã°£ 09-27 203-204 (2F) 08:40~09:00 SY07: Post-management of in vitro diagnostic devices and monitoring of side effects  Segu Kang(Ministry of Food and Drug Safety Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 09:00~09:20 SY07: Experience in establishment of MFDS reference standards and their usage in laboratory  Hee Jin Huh(Dongguk University College of Medicine Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 09:20~09:40 SY07: Experience of MFDS standard material and unmet need  Hae Joon Park(SD Biosensor Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 09:50~10:15 SY07: IVD Authorazation Process  Seung-Rel Ryu(Ministry of Food and Drug Safety) 
±³À°½Ã°£ 09-27 203-204 (2F) 10:15~10:40 SY07: Introduction of IVD Productification Support Program  Ji Hun Cha(Ministry of Food and Drug Safety) 
±³À°½Ã°£ 09-27 205 (2F) 11:00~12:00 PL02: Immunoassay interferences and their impact on patient care  Carmen L. Wiley(AACC USA) 
±³À°½Ã°£ 09-27 205 (2F) 13:00~13:30 SY08: Fluid and imaging biomarkers toward the development of therapies for Alzheimer  Takeshi Iwatsubo(The University of Tokyo Japan) 
±³À°½Ã°£ 09-27 205 (2F) 13:30~14:00 SY08: Pre-analytical and Analytical Considerations for the Implementation of AD biomarkers in the Clinical Laboratory  Alicia Algeciras-Schimnich(Mayo Clinic USA) 
±³À°½Ã°£ 09-27 205 (2F) 14:00~14:30 SY08: Biomarkers of Alzheimer  Ae Young Lee(Department of Neurology Chungnam National University College of Medicine Korea) 
±³À°½Ã°£ 09-27 201-202 (2F) 13:00~13:40 SY09: Multiplex assay application for the diagnosis of autoimmune disease  Marvin Fritzler(University of Calgary Canada) 
±³À°½Ã°£ 09-27 201-202 (2F) 13:40~14:05 SY09: Soluble type immune regulatory molecule assays in the field of cancer immunotherapy  Jong-Han Lee(Yonsei University Wonju College of Medicine Korea) 
±³À°½Ã°£ 09-27 201-202 (2F) 14:05~14:30 SY09: Multiplex Ag/Ab assay for the diagnosis of infectious diseases  Jaehyeon Lee(Chonbuk National University Medical School Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 13:00~13:30 SY10: Accreditation of Surveyor Training Programme by the International Society for Quality in Health Care External Evaluation Association (IEEA)  Lena Low(The Australian Council on Healthcare Standards Australia) 
±³À°½Ã°£ 09-27 203-204 (2F) 13:30~14:00 SY10: Management and Education for surveyors in Korea Institute for Healthcare Accreditation  Hyun Ji Baek(Korea Institute for Healthcare Accreditation Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 14:00~14:30 SY10: Introduction of Inspector Training Program by LMF  Jihyang Lim(The Catholic University of Korea College of Medicine Korea) 
±³À°½Ã°£ 09-27 101-102 (1F) 13:00~13:30 SY11: Comparing the perceptions and opinions of clinicians and laboratory medicine physicians about new DRG, laboratory test utilization and quality incentive  Yong-jun Choi(Department of Social and Preventive Medicine Hallym University College of Medicine Korea) 
±³À°½Ã°£ 09-27 101-102 (1F) 13:30~14:00 SY11: Comparison of laboratory test quality between laboratories with or without participating in New DRG: analysis of KEQAS data  Sollip Kim(Inje University Ilsan Paik Hospital Korea) 
±³À°½Ã°£ 09-27 101-102 (1F) 14:00~14:30 SY11: Comparison the Laboratory Test Utilization after introduction of New DRG by analyzing the health insurance claim data  Hyeongsu Kim(Department of Preventive Medicine School of Medicine Konkuk University Korea) 
±³À°½Ã°£ 09-27 205 (2F) 15:00~15:30 SY12: RNA sequencing in leukemia research  Zhaolei Zhang(University of Toronto Faculty of Medicine Canada) 
±³À°½Ã°£ 09-27 205 (2F) 15:30~16:00 SY12: Single cell RNA sequencing for biomedical research  Dave Tang(University of Western Australia Australia) 
±³À°½Ã°£ 09-27 205 (2F) 16:00~16:30 SY12: Clinical application of RNA sequencing  Seung-Tae Lee(Yonsei University College of Medicine Korea) 
±³À°½Ã°£ 09-27 201-202 (2F) 15:00~15:40 SY13: International Consensus on ANA pattern (ICAP): Nuclear patterns and their clinical relevance  Luis E.C. Andrade(Federal University of Sao Paulo Brazil) 
±³À°½Ã°£ 09-27 201-202 (2F) 15:40~16:20 SY13: Cytoplasmic ICAP patterns and their clinical relevance  Edward K.L. Chan(University of Florida USA) 
±³À°½Ã°£ 09-27 201-202 (2F) 16:20~16:40 SY13: Current status for ANA reporting in Korea  Kyeong-Hee Kim(Dong-A University College of Medicine Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 15:00~15:30 SY14: Laboratory Leadership: A Critical Role Inside and Beyond the Laboratory  Richard C. Friedberg(Baystate Medical Center USA) 
±³À°½Ã°£ 09-27 203-204 (2F) 15:30~16:00 SY14: Comparison of CAP and LMF Accreditation Programs – a Viewpoint from an Inspected Laboratory  Sang Hoon Song(Seoul National University College of Medicine Korea) 
±³À°½Ã°£ 09-27 203-204 (2F) 16:00~16:30 SY14: Human Resouce Management  Hwan Sub Lim(Seoul Clinical Laboratories Korea) 
±³À°½Ã°£ 09-27 205 (2F) 17:00~17:40 KS02: Integration of genomics and artificial intelligence drives precision oncology  Marilyn M. Li(University of Pennsylvania USA) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ LMCE 2019 & 60Â÷ Ãß°èÇмú´ëȸ : 2019-09-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °è¸í´ëÇб³ µ¿»êº´¿ø °³¿ø±â³ä Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2019-09-27
´ÙÀ½±Û â¿ø°æ»ó´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ±Ý¿ä¼¼¹Ì³ª : 2019-09-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20560 °æ±â 2024 ¼º³²½ÃÀÇ»çȸ »ó¹Ý±â Çмú´ëȸ : 2024-06-01 0 3 2024-04-29
20559 °æ±â Á¦34Â÷ Áß¾Ó´ëÇб³ ºñ´¢ÀÇÇаú ¿öÅ©¼¥ : 2024-06-01 0 24 2024-04-29
20558 ±¤ÁÖ Á¦2ȸ ´ëÇѺñ¸¸ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2024-06-01 0 21 2024-04-29
20557 ÀÎõ 2024³â ±èÆ÷½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 8 2024-04-29
20556 ¼­¿ï 2024 ´ëÇÑ¿ì¿ïÇൿ½Å°æÇבּ¸È¸ Ãá°èÇмú´ëȸ : 2024-06-01 0 9 2024-04-29
20555 ¼­¿ï ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ Á¦38Â÷ Ãá°èÅëÇÕÇмú´ëȸ ¹× ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-06-01 0 10 2024-04-29
20554 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-01 0 12 2024-04-29
20553 ¼­¿ï 2024³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 21 2024-04-29
20552 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦297Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-31 0 17 2024-04-29
20551 ¼­¿ï (¿Â¶óÀÎ) 2024 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 39 2024-04-29
20550 ºÎ»ê Á¦ 169Â÷ ºÎ»êÁö¹æ³²¼º°úÇÐȸ Çмú´ëȸ : 2024-05-31 0 11 2024-04-29
20549 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦26ȸ ¿¬¼ö°­Á : 2024-05-30 0 6 2024-04-29
20548 °­¿ø 2024³â ¿øÁÖ½ÃÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß : 2024-05-28 0 11 2024-04-29
20547 °æ±â Á¦4ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿Ü°ú³»½Ã°æ ¿¬¼ö°­Á : 2024-05-26 0 18 2024-04-29
20546 ¼­¿ï ´ëÇѺñ´¢ÃÊÀ½ÆÄÇÐȸ Á¦17Â÷ Çмú´ëȸ : 2024-05-26 0 7 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷